Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v8-EN
Language English English
Date Updated 2020-03-26 2020-03-26
Drug Identification Number 02432889 02432889
Brand name DYMISTA DYMISTA
Common or Proper name FLUTICASONE PROPIONATE azelastine hydrochloride FLUTICASONE PROPIONATE azelastine hydrochloride
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients FLUTICASONE PROPIONATE AZELASTINE HYDROCHLORIDE FLUTICASONE PROPIONATE AZELASTINE HYDROCHLORIDE
Strength(s) 50MCG 137MCG 50MCG 137MCG
Dosage form(s) SPRAY, METERED DOSE SPRAY, METERED DOSE
Route of administration NASAL NASAL
Packaging size 25 ML 25 ML
ATC code R01AD R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-03-16 2020-03-16
Actual start date 2020-03-17 2020-03-17
Estimated end date 2020-03-23 2020-03-23
Actual end date 2020-03-25 2020-03-25
Shortage status Resolved Resolved
Company comments
Health Canada comments